U24DA057650
Cooperative Agreement
Overview
Grant Description
Heal Data2Action Modeling and Economic Resource Center
The Heal Data2Action (D2A) program is a coordinated effort to promote the synthesis and real-world application of existing data to guide and monitor improvements in service delivery to prevent or treat opioid use disorder (OUD) and pain. Collectively, these projects will address gaps in the delivery of evidence-based practices in each of the four pillars of the HHS overdose prevention strategy: primary prevention, harm reduction, treatment of opioid use disorder, and recovery support.
The Heal D2A Modeling and Economic Resource Center (MERC) will support the Heal D2A innovation projects by providing expertise in simulation modeling and economic evaluation methods. The MERC will consult with the Heal D2A innovation grant recipients on applying these methods and insights in their local implementation activities. Additionally, the MERC will conduct original research applying state-of-the-art economic and simulation modeling expertise to understand and address the overdose crisis.
Since 2015, we have worked collaboratively to lead a highly successful multi-institutional NIDA-funded national center of excellence, the Center for Health Economics of Treatment Interventions for Substance Use Disorder, HCV, and HIV (CHERISH). We are thus uniquely qualified to lead the Heal D2A MERC with the following aims:
1) To support the Heal D2A innovation projects by providing methodological consultation on the application of rigorous modeling techniques, cost analyses, and behavioral economic strategies. This support will help the projects select and implement evidence-based practices to address service delivery needs.
2) To develop tools that can be readily used by the innovation projects to make informed decisions about the relative costs of different implementation interventions to different stakeholders. These tools will also measure the overall costs of these efforts and inform the design of appropriate payment systems that support sustainability.
3) To use meta-modeling techniques to develop a user-friendly interface so that simulation model results generated for one system or community can be adapted for other systems/communities or adapted when local circumstances change.
4) To conduct novel research using advanced modeling and health economics approaches that build on existing data. This research will provide insights into the complex dynamics of addressing the overdose crisis through strategic implementation of evidence-based practices.
The Heal D2A MERC will support the application of health economics and modeling research to real-world decision making about services to prevent or treat opioid use disorder and pain. It will further scientific innovation in the field and establish a paradigm for integrating health economics and modeling into substance use treatment and prevention policies at the system level.
The Heal D2A MERC will be collaborative with the work of the Heal D2A Research Adoption Support Center (RASC), including the consultations and catalog of measures and tools of the implementation support cores. It will also leverage and contribute to the resources of the Heal D2A Data Infrastructure Support Center (DISC).
The Heal Data2Action (D2A) program is a coordinated effort to promote the synthesis and real-world application of existing data to guide and monitor improvements in service delivery to prevent or treat opioid use disorder (OUD) and pain. Collectively, these projects will address gaps in the delivery of evidence-based practices in each of the four pillars of the HHS overdose prevention strategy: primary prevention, harm reduction, treatment of opioid use disorder, and recovery support.
The Heal D2A Modeling and Economic Resource Center (MERC) will support the Heal D2A innovation projects by providing expertise in simulation modeling and economic evaluation methods. The MERC will consult with the Heal D2A innovation grant recipients on applying these methods and insights in their local implementation activities. Additionally, the MERC will conduct original research applying state-of-the-art economic and simulation modeling expertise to understand and address the overdose crisis.
Since 2015, we have worked collaboratively to lead a highly successful multi-institutional NIDA-funded national center of excellence, the Center for Health Economics of Treatment Interventions for Substance Use Disorder, HCV, and HIV (CHERISH). We are thus uniquely qualified to lead the Heal D2A MERC with the following aims:
1) To support the Heal D2A innovation projects by providing methodological consultation on the application of rigorous modeling techniques, cost analyses, and behavioral economic strategies. This support will help the projects select and implement evidence-based practices to address service delivery needs.
2) To develop tools that can be readily used by the innovation projects to make informed decisions about the relative costs of different implementation interventions to different stakeholders. These tools will also measure the overall costs of these efforts and inform the design of appropriate payment systems that support sustainability.
3) To use meta-modeling techniques to develop a user-friendly interface so that simulation model results generated for one system or community can be adapted for other systems/communities or adapted when local circumstances change.
4) To conduct novel research using advanced modeling and health economics approaches that build on existing data. This research will provide insights into the complex dynamics of addressing the overdose crisis through strategic implementation of evidence-based practices.
The Heal D2A MERC will support the application of health economics and modeling research to real-world decision making about services to prevent or treat opioid use disorder and pain. It will further scientific innovation in the field and establish a paradigm for integrating health economics and modeling into substance use treatment and prevention policies at the system level.
The Heal D2A MERC will be collaborative with the work of the Heal D2A Research Adoption Support Center (RASC), including the consultations and catalog of measures and tools of the implementation support cores. It will also leverage and contribute to the resources of the Heal D2A Data Infrastructure Support Center (DISC).
Funding Goals
TO SUPPORT BASIC AND CLINICAL NEUROSCIENCE, BIOMEDICAL, BEHAVIORAL AND SOCIAL SCIENCE, EPIDEMIOLOGIC, HEALTH SERVICES AND HEALTH DISPARITY RESEARCH. TO DEVELOP NEW KNOWLEDGE AND APPROACHES RELATED TO THE PREVENTION, DIAGNOSIS, TREATMENT, ETIOLOGY, AND CONSEQUENCES OF DRUG ABUSE AND ADDICTION, INCLUDING HIV/AIDS. TO SUPPORT RESEARCH TRAINING AND RESEARCH SCIENTIST DEVELOPMENT. TO SUPPORT DISSEMINATION OF RESEARCH FINDINGS. SMALL BUSINESS INNOVATION RESEARCH (SBIR) LEGISLATION IS INTENDED TO EXPAND AND IMPROVE THE SBIR PROGRAMS TO EMPHASIZE AND INCREASE PRIVATE SECTOR COMMERCIALIZATION OF TECHNOLOGY DEVELOPED THROUGH FEDERAL SBIR RESEARCH AND DEVELOPMENT, INCREASE SMALL BUSINESS PARTICIPATION IN FEDERAL RESEARCH AND DEVELOPMENT, AND FOSTER AND ENCOURAGE PARTICIPATION OF SOCIALLY AND ECONOMICALLY DISADVANTAGED SMALL BUSINESS CONCERNS AND WOMEN-OWNED SMALL BUSINESS CONCERNS IN THE SBIR PROGRAM. THE LEGISLATION INTENDS THAT THE SMALL BUSINESS TECHNOLOGY TRANSFER (STTR) PROGRAM STIMULATE AND FOSTER SCIENTIFIC AND TECHNOLOGICAL INNOVATION THROUGH COOPERATIVE RESEARCH AND DEVELOPMENT CARRIED OUT BETWEEN SMALL BUSINESS CONCERNS AND RESEARCH INSTITUTIONS, FOSTER TECHNOLOGY TRANSFER BETWEEN SMALL BUSINESS CONCERNS AND RESEARCH INSTITUTIONS, TO INCREASE PRIVATE SECTOR COMMERCIALIZATION OF INNOVATIONS DERIVED FROM FEDERAL RESEARCH AND DEVELOPMENT, AND FOSTER AND ENCOURAGE PARTICIPATION OF SOCIALLY AND ECONOMICALLY DISADVANTAGED SMALL BUSINESS CONCERNS AND WOMEN-OWNED SMALL BUSINESS CONCERNS IN TECHNOLOGICAL INNOVATION.
Grant Program (CFDA)
Awarding / Funding Agency
Place of Performance
New York,
New York
100654805
United States
Geographic Scope
Single Zip Code
Related Opportunity
Analysis Notes
Amendment Since initial award the total obligations have increased 273% from $1,755,961 to $6,550,146.
Weill Medical College Of Cornell University was awarded
HEAL Data2Action Modeling and Economic Resource Center
Cooperative Agreement U24DA057650
worth $6,550,146
from National Institute on Drug Abuse in September 2022 with work to be completed primarily in New York New York United States.
The grant
has a duration of 5 years and
was awarded through assistance program 93.279 Drug Abuse and Addiction Research Programs.
The Cooperative Agreement was awarded through grant opportunity HEAL Initiative: HEAL Data2Action Modeling and Economic Resource Center (U24 Clinical Trial Optional).
Status
(Ongoing)
Last Modified 8/20/25
Period of Performance
9/30/22
Start Date
8/31/27
End Date
Funding Split
$6.6M
Federal Obligation
$0.0
Non-Federal Obligation
$6.6M
Total Obligated
Activity Timeline
Transaction History
Modifications to U24DA057650
Additional Detail
Award ID FAIN
U24DA057650
SAI Number
U24DA057650-139556473
Award ID URI
SAI UNAVAILABLE
Awardee Classifications
Private Institution Of Higher Education
Awarding Office
75N600 NIH National Insitute on Drug Abuse
Funding Office
75N600 NIH National Insitute on Drug Abuse
Awardee UEI
YNT8TCJH8FQ8
Awardee CAGE
1UMU6
Performance District
NY-12
Senators
Kirsten Gillibrand
Charles Schumer
Charles Schumer
Budget Funding
Federal Account | Budget Subfunction | Object Class | Total | Percentage |
---|---|---|---|---|
National Institute on Drug Abuse, National Institutes of Health, Health and Human Services (075-0893) | Health research and training | Grants, subsidies, and contributions (41.0) | $3,388,192 | 100% |
Modified: 8/20/25